PuSH - Publication Server of Helmholtz Zentrum München: Dual role of the adaptive immune system in liver injury and hepatocellular carcinoma development.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Endig, J.* ; Buitrago-Molina, L.E.* ; Marhenke, S.* ; Reisinger, F. ; Saborowski, A.* ; Schütt, J.* ; Limbourg, F.* ; Könecke, C.* ; Schreder, A.* ; Michael, A.* ; Misslitz, A.C.* ; Healy, M.E.* ; Geffers, R.* ; Clavel, T.* ; Haller, D.* ; Unger, K. ; Finegold, M.* ; Weber, A.* ; Manns, M.P.* ; Longerich, T.* ; Heikenwälder, M.* ; Vogel, A.*

Dual role of the adaptive immune system in liver injury and hepatocellular carcinoma development.

Cancer Cell 30, 308-323 (2016)

Publ. Version/Full Text

Postprint

Research data

DOI

PMC

	Open Access Green

Abstract
Metrics
Extra information

Hepatocellular carcinoma (HCC) represents a classic example of inflammation-linked cancer. To characterize the role of the immune system in hepatic injury and tumor development, we comparatively studied the extent of liver disease and hepatocarcinogenesis in immunocompromised versus immunocompetent Fah-deficient mice. Strikingly, chronic liver injury and tumor development were markedly suppressed in alymphoid Fah(-/-) mice despite an overall increased mortality. Mechanistically, we show that CD8(+) T cells and lymphotoxin β are central mediators of HCC formation. Antibody-mediated depletion of CD8(+) T cells as well as pharmacological inhibition of the lymphotoxin-β receptor markedly delays tumor development in mice with chronic liver injury. Thus, our study unveils distinct functions of the immune system, which are required for liver regeneration, survival, and hepatocarcinogenesis.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Hereditary Tyrosinemia Type-1; Hepatic-dysfunction; Tumor-development; T-cells; Hepatocytes; Cancer; Regeneration; Mice; Fumarylacetoacetate; Pathogenesis

ISSN (print) / ISBN 1535-6108

e-ISSN 1878-3686

Journal Cancer Cell

Quellenangaben Volume: 30, Issue: 8, Pages: 308-323

Publisher Cell Press

Publishing Place Cambridge, Mass.

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Virology (VIRO)
Research Unit Radiation Cytogenetics (ZYTO)